Orion Pharma profit falls by 50pc to Tk 31.82cr in FY 24

The profit of the Orion Pharma of the Orion Group declined 50 percent to Tk 31.82 crore in the fiscal year (FY) ending June 30, 2024, compared to FY 2022-23.

Its consolidated earnings per share (EPS) fell to Tk 1.36 from Tk 2.74 in the previous year, according to a disclosure on the website of the Dhaka Stock Exchange.

Its net operating cash flow per share (NOCFPS) also weakened, with a consolidated NOCFPS of Tk 6.78, down from Tk 10.65 in FY23. Despite the situation Orion Pharma recommended a 10 percent cash dividend for its shareholders.